Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2022

May 11, 2022

BUY
$3.0 - $4.25 $46,200 - $65,450
15,400 Added 18.67%
97,900 $68,000
Q4 2021

Feb 08, 2022

BUY
$3.85 - $6.71 $10,395 - $18,117
2,700 Added 3.38%
82,500 $72,000
Q3 2021

Nov 02, 2021

SELL
$5.6 - $8.58 $134,960 - $206,778
-24,100 Reduced 23.2%
79,800 $146,000
Q2 2021

Aug 11, 2021

SELL
$7.16 - $9.41 $22,196 - $29,171
-3,100 Reduced 2.9%
103,900 $352,000
Q1 2021

May 14, 2021

BUY
$7.52 - $15.55 $4,512 - $9,330
600 Added 0.56%
107,000 $400,000
Q4 2020

Feb 12, 2021

BUY
$5.0 - $8.85 $532,000 - $941,640
106,400 New
106,400 $278,000

Others Institutions Holding CRON

About Cronos Group Inc.


  • Ticker CRON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 377,896,000
  • Market Cap $760M
  • Description
  • Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of...
More about CRON
Track This Portfolio

Track Raymond James & Associates Portfolio

Follow Raymond James & Associates and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.